Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Drug Alcohol Depend. 2019 Sep 27;205:107596. doi: 10.1016/j.drugalcdep.2019.107596

Table.2.

Number of subjects with ECG and PK data at each study time point (C-QTcF population).

Time Number of subjects
LFX 2.16 mg LFX 2.88 mg Placebo
DAY 1: pre 1 pm dose 202 194 151
DAY 1: 4 pm 200 187 139
DAY 1: 5 pm 191 182 135
DAY 2: pre 8 am dose 177 172 118
DAY 4: pre 8 am dose 114 119 74
DAY 7: pre 8 am dose 91 99 58
DAY 7: pre 1 pm dose 54 68 37
DAY 7: 4 pm 54 63 37
DAY 7: 5 pm 54 65 37

ECG, electrocardiogram; LFX, lofexidine; PK, pharmacokinetics.